{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:42:51Z","timestamp":1767840171261,"version":"3.49.0"},"reference-count":29,"publisher":"Japan Epidemiological Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Epidemiology"],"published-print":{"date-parts":[[2022,3,5]]},"DOI":"10.2188\/jea.je20200207","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T22:07:09Z","timestamp":1604095629000},"page":"117-124","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of the Use of Oral Contraceptives and Hormone Replacement Therapy in Japan: The Japan Nurses\u2019 Health Study"],"prefix":"10.2188","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-7049","authenticated-orcid":false,"given":"Toshiyuki","family":"Yasui","sequence":"first","affiliation":[{"name":"Department of Reproductive and Menopausal Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ideno","sequence":"additional","affiliation":[{"name":"Center for Mathematics and Data Science, Gunma University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-3011","authenticated-orcid":false,"given":"Hiromitsu","family":"Shinozaki","sequence":"additional","affiliation":[{"name":"Graduate School of Health Sciences, Gunma University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Gunma University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2562-2127","authenticated-orcid":false,"given":"Kazue","family":"Nagai","sequence":"additional","affiliation":[{"name":"Graduate School of Health Sciences, Gunma University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4648-3936","authenticated-orcid":false,"given":"Kunihiko","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Graduate School of Health Sciences, Gunma University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"991","reference":[{"key":"1","unstructured":"1. Mosher WD, Jones J. Use of contraception in the United States: 1982\u20132008. <i>Vital Health Stat<\/i>. 2010;23:1\u201344."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yoshida H, Sakamoto H, Leslie A, Takahashi O, Tsuboi S, Kitamura K. Contraception in Japan: current trends. <i>Contraception<\/i>. 2016;93:475\u2013477.","DOI":"10.1016\/j.contraception.2016.02.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rossouw JE, Anderson GL, Prentice RL, et\u00a0al; The Writing Group for the WHI Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results of the Women\u2019s Health Initiative randomized controlled trial. <i>JAMA<\/i>. 2002;288(3):321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Anderson GL, Limacher M, Assaf AR, et\u00a0al; Women\u2019s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women\u2019s Health Initiative Randomized Controlled Trial. <i>JAMA<\/i>. 2004;291:1701\u20131712.","DOI":"10.1001\/jama.291.14.1701"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. <i>JAMA<\/i>. 2004;291:47\u201353.","DOI":"10.1001\/jama.291.1.47"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ameye L, Antoine C, Paesmans M, de Azambuja E, Rozenberg S. Menopausal hormone therapy use in 17 European countries during the last decade. <i>Maturitas<\/i>. 2014;79:287\u2013291.","DOI":"10.1016\/j.maturitas.2014.07.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. de Villiers TJ, Hall JE, Pinkerton JV, et\u00a0al. Revised global consensus statement on menopausal hormone therapy. <i>Climacteric<\/i>. 2016;19:313\u2013315.","DOI":"10.1080\/13697137.2016.1196047"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN. Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. <i>Atherosclerosis<\/i>. 2016;254:282\u2013290.","DOI":"10.1016\/j.atherosclerosis.2016.10.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries. <i>Maturitas<\/i>. 2016;84:81\u201388.","DOI":"10.1016\/j.maturitas.2015.11.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Peng W, Adams J, Hickman L, Sibbritt DW. Complementary\/alternative and conventional medicine use among menopausal women: results from the Australian longitudinal study on women\u2019s health. <i>Maturitas<\/i>. 2014;79:340\u2013342.","DOI":"10.1016\/j.maturitas.2014.08.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagata C, Matsushita Y, Shimizu H. Prevalence of hormone replacement therapy and user\u2019s characteristics: a community survey in Japan. <i>Maturitas<\/i>. 1996;25:201\u2013207.","DOI":"10.1016\/S0378-5122(96)01067-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Crawford SL, Crandall CJ, Derby CA, et\u00a0al. Menopausal hormone therapy trends before versus after 2002: impact of the Women\u2019s Health Initiative Study Results. <i>Menopause<\/i>. 2018;26:588\u2013597.","DOI":"10.1097\/GME.0000000000001282"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bhupathiraju SN, Grodstein F, Rosner BA, et\u00a0al. Hormone therapy use and risk of chronic disease in the Nurses\u2019 Health Study: a comparative analysis with the Women\u2019s Health Initiative. <i>Am J Epidemiol<\/i>. 2017;186:696\u2013708.","DOI":"10.1093\/aje\/kwx131"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hundrup YA, Ekholm O, H\u00f8idrup S, Davidsen M, Obel EB. Risk factors for hip fracture and a possible effect modification by hormone replacement therapy. The Danish Nurse Cohort Study. <i>Eur J Epidemiol<\/i>. 2005;20:871\u2013877.","DOI":"10.1007\/s10654-005-2151-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. L\u00f8kkegaard E, Nielsen LH, Keiding N. Risk of stroke with various types of menopausal hormone therapies. A national cohort study. <i>Stroke<\/i>. 2017;48:2266\u20132269.","DOI":"10.1161\/STROKEAHA.117.017132"},{"key":"16","unstructured":"16. Rothman KJ, Greenland S, Lash TL. <i>Modern epidemiology<\/i>. 3<sup>rd<\/sup> ed. Lippincott Williams &amp; Wilkins. Philadelphia. 2008:46\u201349."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hayashi K, Mizunuma H, Fujita T, et\u00a0al. Design of the Japan Nurses\u2019 Health Study: a prospective occupational cohort study of women\u2019s health in Japan. <i>Ind Health<\/i>. 2007;45:679\u2013686.","DOI":"10.2486\/indhealth.45.679"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yasui T, Hayashi K, Mizunuma H, et\u00a0al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. <i>Maturitas<\/i>. 2012;72:249\u2013255.","DOI":"10.1016\/j.maturitas.2012.04.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lundberg V, Tolonen H, Stegmayr B, Kuulasmaa K, Asplund K; WHO MONICA Project. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. <i>Maturitas<\/i>. 2004;48:39\u201349.","DOI":"10.1016\/j.maturitas.2003.08.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rashed AN, Hsia Y, Wilton L, Ziller M, Kostev K, Tomlin S. Trends and patterns of hormonal contraceptive prescribing for adolescents in primary care in the UK. <i>J Fam Plann Reprod Health Care<\/i>. 2015;41:216\u2013222.","DOI":"10.1136\/jfprhc-2013-100724"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kitamura K. The pill in Japan: will approval ever come? <i>Fam Plann Perspect<\/i>. 1999;31:44\u201345.","DOI":"10.2307\/2991557"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kinoshita T, Tanaka S, Inagaki M, Takeuchi M, Kawakami K. Prescription pattern and trend of oral contraceptives in Japan: a descriptive study based on pharmacy claims data (2006\u20132014). <i>Sex Reprod Healthc<\/i>. 2018;17:50\u201355.","DOI":"10.1016\/j.srhc.2018.06.004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Strothmann A, Schneider HPG. Hormone therapy: the European women\u2019s perspective. <i>Climacteric<\/i>. 2003;6:337\u2013346.","DOI":"10.1080\/cmt.6.4.337.346"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okano H, Higuchi T, Kurabayashi T, et\u00a0al; Subcommittee for Revising the Japanese Guidelines for Hormone Replacement Therapy in the Women\u2019s Health Care Committee, Japan Society of Obstetrics and Gynecology. Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women\u2019s Health 2017 guidelines for hormone replacement therapy. <i>J Obstet Gynaecol Res<\/i>. 2018;44:1355\u20131368.","DOI":"10.1111\/jog.13684"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Du Y, D\u00f6ren M, Melchert HUW, Scheidt-Nave C, Knopf H. Differences in menopausa hormone therapy use among women in Germany between 1998 and 2003. <i>BMC Womens Health<\/i>. 2007;7:19.","DOI":"10.1186\/1472-6874-7-19"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Baber RJ, Panay N, Fenton A; IMS Writing Group. 2016 IMS recommendations on women\u2019s midlife health and menopause hormone therapy. <i>Climacteric<\/i>. 2016;19:109\u2013150.","DOI":"10.3109\/13697137.2015.1129166"},{"key":"27","unstructured":"27. Banks E, Barnes I, Baker K, Key TJ; EPIC Working Group on Reproductive and Hormonal Factors. Use of hormone therapy for menopause in nine European countries. <i>IARC Sci Publ<\/i>. 2002;156:301\u2013303."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Buist DSM, Newton KM, Miglioretti DL, et\u00a0al. Hormone therapy prescribing patterns in the United States. <i>Obstet Gynecol<\/i>. 2004;104:1042\u20131050.","DOI":"10.1097\/01.AOG.0000143826.38439.af"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Manzoli L, Di Giovanni P, Del Duca L, et\u00a0al. Use of hormone replacement therapy in Italian women aged 50\u201370 years. <i>Maturitas<\/i>. 2004;49:241\u2013251.","DOI":"10.1016\/j.maturitas.2004.02.003"}],"container-title":["Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/32\/3\/32_JE20200207\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:13:59Z","timestamp":1646453639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/32\/3\/32_JE20200207\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2188\/jea.je20200207","relation":{},"ISSN":["0917-5040","1349-9092"],"issn-type":[{"value":"0917-5040","type":"print"},{"value":"1349-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"article-number":"JE20200207"}}